메뉴 건너뛰기




Volumn 94, Issue 4 SUPPL., 2002, Pages 1363-1372

High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support: Results of a pilot study

Author keywords

Anti CD20 antibody; High dose myeloablative therapy; Mantle cell non Hodgkin lymhpoma; Radioimmunotherapy; Stem cell transplantation

Indexed keywords

CD20 ANTIGEN; IODINE 131; RITUXIMAB;

EID: 0037083476     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10307     Document Type: Conference Paper
Times cited : (62)

References (21)
  • 18
    • 0030002992 scopus 로고    scopus 로고
    • MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine
    • (1996) J Nucl Med , vol.37 , pp. 538-546
    • Stabin, M.G.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.